Gerber Scientific, Inc. GRB today reported revenue and operating results for its fiscal 2011 second quarter ended October 31, 2010.
- Reported revenue increased 9.0% to $129.3 million from $118.7 million.
- Gross profit was $38.6 million or 29.9% of sales versus $35.2 million or 29.7% of sales. Prior year gross margin was 29.0% excluding licensing revenue. The impact of foreign currency exchange rates reduced gross profit approximately $0.6 million;
- Selling, general and administrative (SG&A) expenses were $29.5 million, or 22.8% of sales, compared with $27.5 million, or 23.2% of sales. The current quarter includes the restoration of approximately $1.5 million in temporary wage reductions and $0.8 million in incentive compensation. Changes in foreign currency exchange rates lowered current quarter expenses approximately $0.6 million;
- Excluding goodwill impairment from the current quarter and restructuring charges from both periods, operating income was up 35.3% to $4.7 million compared with $3.5 million. Reported operating loss was $14.4 million compared with operating income of $2.9 million, reflecting a $16.9 million goodwill impairment charge in connection with the previously announced sale of the ophthalmic lens processing business and $2.2 million of restructuring and other expenses.
- Loss from continuing operations was $16.1 million, or $0.64 per diluted share, compared to income of $2.0 million, or $0.08 per diluted share. Net loss for the current quarter was $16.1 million, or $0.64 per diluted share, compared with income of $0.5 million, or $0.02 per diluted share. Excluding the goodwill impairment charge, diluted earnings per share were $0.03 per share;
- Net cash flows from operations, less capital expenditures, increased $3.6 million to $4.0 million, from $0.4 million in the prior year, due principally to working capital improvements;
- Total outstanding debt fell to $35.0 million, representing a $3.0 million reduction in the quarter and a $10.0 million reduction since April 30, 2010
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in